United Kingdom· GB-APID-23878311000001104
Disopyramide 100mg capsules
A disopyramide product containing disopyramide, registered in United Kingdom by DE Pharmaceuticals. The same ATC class is registered in 9 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Disopyramide is registered in 9 of 19 countries.
Countries holding a registration under ATC C01BA03 (disopyramide), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 5 of them publish a price we can compare per daily dose
Disopyramide · ATC C01BA03
9 / 19 countries
- Belgiumprice
- Canada
- Finlandprice
- Franceprice
- Japan
- Netherlands
- Norwayprice
- United Kingdom
- United Statesprice
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Disopyramide
- Manufacturer
- DE Pharmaceuticals
- Country
- United Kingdom (GB)
- ATC code
- C01BA03
- ATC class
- Disopyramide
- Defined daily dose
- 0.4 g, O
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
341 interactions on record for disopyramide.
Graded by severity as the source publishes them — 138 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Disopyramide · interactions on record
341 records
- 138 severe
- 182 moderate
- 10 minor
- 11 info
Most severe, free to view
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- OndansetronA04AA01severe
- GranisetronA04AA02severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Disopyramide in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesDisopyramide PhosphateTeva Pharmaceuticals USA, Inc.
- SpainDICORYNAN 100 mg CAPSULAS DURASCheplapharm Arzneimittel Gmbh
- BelgiumRythmodan 100 mgCheplapharm Arzneimittel
- FranceRYTHMODAN 100 mg, géluleCHEPLAPHARM ARZNEIMITTEL (ALLEMAGNE)
- FinlandDurbissanofi-Aventis Oy
- CanadaRYTHMODANCHEPLAPHARM ARZNEIMITTEL GMBH
- NorwayRitmodan RetardSanofi
- ItalyRITMODAN RETARD*20 cpr 250 mgCHEPLAPHARM ARZNEIMITTEL GMBH
Authorised across Europe · EMA
The same active substance is authorised in 6 EEA countries. Names it is sold under:
- Belgium · Rythmodan, Rythmodan Long Action
- Spain · Dicorynan
- France · Isorythm L.P., Rythmodan
- Italy · Ritmodan, Ritmodan Retard
- Luxembourg · Rythmodan, Rythmodan Long Action
- Netherlands · Ritmoforine Retard
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/cfa7023c-238f-4e44-af0f-3922b5c4dab9 GET /v1/drugs/cfa7023c-238f-4e44-af0f-3922b5c4dab9?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "23878311000001104",
"desc": "Disopyramide 100mg capsules (DE Pharmaceuticals)",
"form": "Oral capsule",
"vpid": "39690511000001109",
"source": "dmd",
"vtm_id": "773247002",
"strength": "100 mg",
"substance": "Disopyramide",
"ingredient": "Disopyramide",
"supplier_code": "2268901000001109"
}See everything about disopyramide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.